BEPRANEMAB
UNII 9M1GV6L389

Substance Identification & Data

This profile provides standardized clinical and technical data for Bepranemab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9M1GV6L389.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2244960-75-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9M1GV6L389

CAS Registry Number

2244960-75-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BEPRANEMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C174583

National Cancer Institute reference terminology for clinical and research data.

INN ID

11224

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-171

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bepranemab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BEPRANEMAB

Common Names & Synonyms

BEPRANEMAB [INN]

BEPRANEMAB [USAN]

IMMUNOGLOBULIN G4 (226-PROLINE), ANTI-(HUMAN TAU PROTEIN) (HUMAN-RATTUS NORVEGICUS MONOCLONAL UCB0107 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-RATTUS NORVEGICUS MONOCLONAL UCB0107 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS MAPT (MICROTUBULE ASSOCIATED PROTEIN TAU, TAU)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HUMANIZED (1-445) (VH (HOMO SAPIENS IGHV4-4*08 (83.5%)-(IGHD)- IGHJ3*01 (93.3%)) CDR-IMGT (8.7.12) (26-33.51-57.96-107) (1-118)-HOMO SAPIENS IGHG4*01, G4V5 H P10 (CH1 (119-216), HINGE 1-12 S10>P (226) (217-228), CH2 (229-338), CH3 (339-443), CHS (444-445)) (119-445)), (132- 219')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-219') (V-KAPPA (HOMO SAPIENS IGKV2-29*02 (90.0%)-IGKJ2*01 (100%)) CDRIMGT (11.3.9) (27- 37.55-57.94-102) (1'-112')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (158), V101 (196) (113'-219')); DIMER (224-224'':227-227'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

RECOMBINANT HUMANISED IGG4P KAPPA LIGHT CHAIN GAMMA HEAVY CHAIN ANTI-TAU MONOCLONAL ANTIBODY UCB0107